Udenyca | Pegfilgrastim-cbqv Injection Breastfeeding

Do you know that important immune protective proteins are present in breast milk? Breast milk also contains required vitamins, minerals, saturated and un saturated fats. These things are extremely important for development of healthy brain. If you are taking any medicine for short term or for the chronic reason then that passes in breast milk as well, that is why you should always check the drug with your health care provider. Here at DrLact we try to analyze drugs based on available researches and in this sheet we will present our analysis for Udenyca | Pegfilgrastim-cbqv Injection.

What is Udenyca | Pegfilgrastim-cbqv Injection used for?


UDENYCA is indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia [see Clinical Studies (14)]. Limitations of Use UDENYCA is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation. UDENYCA is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia. (1) Limitations of Use UDENYCA is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.

What are the risk associated with Udenyca | Pegfilgrastim-cbqv Injection usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Udenyca | Pegfilgrastim-cbqv Injection safe for breastfeeding
Pegfilgrastim is the only one ingredient used in manufacturing of Udenyca | Pegfilgrastim-cbqv Injection, Which makes it easier to analyze its effect in breastfeeding. As per our analysis of Pegfilgrastim it is safe to use Udenyca | Pegfilgrastim-cbqv Injection while lactating. We suggest you to check further details below about Pegfilgrastim usage in breastfeeding.

Statement of Manufacturer/Labeler about breastfeeding usage
8.2 Lactation Risk Summary There are no data on the presence of pegfilgrastim products in human milk, the effects on the breastfed child, or the effects on milk production. Other filgrastim products are secreted poorly into breast milk, and filgrastim products are not orally absorbed by neonates. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for UDENYCA and any potential adverse effects on the breastfed child from UDENYCA or from the underlying maternal condition.

Udenyca | Pegfilgrastim-cbqv Injection Breastfeeding Analsys


Pegfilgrastim while Breastfeeding

Safe

CAS Number: 208265-92-3

Non-glycosylated stimulating factor of granulocyte colonies (G-CSF) which is obtained by recombinant technology.The naturally occurring product is found in breast milk. A very high molecular weight explains the insignificant or no excretion into milk that has been observed both with Lenograstim and Filgrastim. Its low oral bioavailability hampers absorption into infant plasma from the breast milk ingested, as for their proteic nature it is degraded in the gastrointestinal tract, not being absorbed. Filgrastim is not absorbed by the infant's gut even during the neonatal period or prematurity. The granulocyte colony-stimulating factor has been used in premature newborns, both on prevention and treatment of neonatal sepsis and/or necrotizing enterocolitis without adverse effects being observed among treated infants. The bovine G-CSF is found in the usual diet of meat eaters.


I already used Udenyca | Pegfilgrastim-cbqv Injection and meanwhile I breastfed my baby should I be concerned?

It is always a good idea to keep your healthcare provider or doctor informed about your drug usage during pregnancy and breastfeeding but if you have not informed your doctor about Udenyca | Pegfilgrastim-cbqv Injection and have used it then do not panic as Udenyca | Pegfilgrastim-cbqv Injection is mostly safe in breastfeeding and should not cause any harm to your baby.


I am nursing mother and my doctor has suggested me to use Udenyca | Pegfilgrastim-cbqv Injection, is it safe?

Usage of Udenyca | Pegfilgrastim-cbqv Injection is safe for nursing mothers and baby, No worries.


If I am using Udenyca | Pegfilgrastim-cbqv Injection, will my baby need extra monitoring?

No


Who can I talk to if I have questions about usage of Udenyca | Pegfilgrastim-cbqv Injection in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Neulasta | Pegfilgrastim Kit
Fulphila | Pegfilgrastim Injection